Outlook Therapeutics (OTLK) Current Taxes: 2015-2020
Historic Current Taxes for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $1.9 million.
- Outlook Therapeutics' Current Taxes rose 0.18% to $1.9 million in Q2 2020 from the same period last year, while for Jun 2020 it was $1.9 million, marking a year-over-year increase of 0.18%. This contributed to the annual value of $1.9 million for FY2019, which is 0.18% up from last year.
- Outlook Therapeutics' Current Taxes amounted to $1.9 million in Q2 2020, which was down 0.00% from $1.9 million recorded in Q1 2020.
- In the past 5 years, Outlook Therapeutics' Current Taxes registered a high of $2.4 million during Q3 2017, and its lowest value of $1.9 million during Q1 2016.
- For the 3-year period, Outlook Therapeutics' Current Taxes averaged around $2.0 million, with its median value being $1.9 million (2020).
- Its Current Taxes has fluctuated over the past 5 years, first increased by 26.82% in 2017, then declined by 21.09% in 2018.
- Outlook Therapeutics' Current Taxes (Quarterly) stood at $1.9 million in 2016, then rose by 26.82% to $2.4 million in 2017, then declined by 21.09% to $1.9 million in 2018, then climbed by 0.18% to $1.9 million in 2019, then grew by 0.18% to $1.9 million in 2020.
- Its Current Taxes was $1.9 million in Q2 2020, compared to $1.9 million in Q1 2020 and $1.9 million in Q4 2019.